Since our study group consisted of early-stage breast cancer patients and patients with high Ki67 index were already excluded from the study in terms of receiving neoadjuvant chemotherapy, we think that there is no correlation between Ki67 index and axillary non-SLN metastasis. Here, MKI67 is linked to breast carcinoma.